Bill > HB305

This bill amends Pennsylvania's insurance law to regulate insulin coverage in health insurance policies by capping out-of-pocket costs for patients at $35 per thirty-day supply of insulin, regardless of the type or amount needed. The legislation specifically prohibits health insurance policies from charging copayments, coinsurance, or deductibles exceeding this amount, while still allowing insurers to offer lower prices if they choose. The bill excludes several types of insurance policies from this requirement, such as accident-only, fixed indemnity, and dental plans. Additionally, the bill mandates that the Attorney General conduct an investigation into insulin drug pricing, gathering information about manufacturers' business practices and pricing strategies. The Attorney General is required to submit a public report to the General Assembly within one year of the law's effective date, which must include a summary of insulin pricing practices, policy recommendations to prevent overpricing, and other relevant information. The law will take effect 60 days after its passage, with the goal of making insulin more affordable and accessible for Pennsylvania residents.

Business and Industry, Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=B&bn=305